What is the best course of treatment for a patient presenting with a hypertensive crisis, considering their medical history and potential underlying conditions?

Hypertensive Crisis Management

Immediate Assessment: Emergency vs. Urgency

The critical first step is determining whether acute target organ damage is present—this distinction alone dictates whether the patient requires ICU admission with IV therapy (emergency) or outpatient management with oral medications (urgency). 1

Define the Crisis Type

• Hypertensive Emergency: BP >180/120 mmHg WITH acute target organ damage—requires immediate ICU admission and IV antihypertensive therapy 1
• Hypertensive Urgency: BP >180/120 mmHg WITHOUT acute target organ damage—managed with oral medications and outpatient follow-up within 2-4 weeks 2

Rapidly Screen for Target Organ Damage

Perform focused assessment for these specific findings 1:

Neurologic damage:

• Altered mental status, somnolence, or lethargy (hypertensive encephalopathy) 1
• Headache with vomiting, visual disturbances, or seizures 1
• Focal neurological deficits suggesting stroke 1

Cardiac damage:

• Chest pain suggesting acute myocardial ischemia/infarction 1
• Dyspnea with pulmonary edema (acute left ventricular failure) 1

Vascular damage:

• Symptoms of aortic dissection (tearing chest/back pain) 1

Renal damage:

• Acute deterioration in renal function 1

Ophthalmologic damage:

• Bilateral retinal hemorrhages, cotton wool spots, or papilledema on fundoscopy (malignant hypertension) 1

Obstetric:

• Eclampsia or severe preeclampsia 1

---

Management of Hypertensive Emergency

ICU Admission and Monitoring

• Admit immediately to ICU for continuous arterial line BP monitoring (Class I recommendation, Level B-NR) 1
• Monitor target organ function serially 1

Blood Pressure Reduction Targets

Standard approach for most emergencies 1:

• First hour: Reduce mean arterial pressure by 20-25% (or SBP by no more than 25%) 1
• Next 2-6 hours: If stable, reduce to 160/100 mmHg 1
• Next 24-48 hours: Cautiously normalize BP 1

Critical exception—Aortic dissection 1:

• Target SBP ≤120 mmHg within 20 minutes 1
• Target heart rate <60 bpm 1

Critical pitfall: Avoid excessive acute drops >70 mmHg systolic—this precipitates cerebral, renal, or coronary ischemia, particularly in patients with chronic hypertension who have altered autoregulation 1

First-Line IV Medications

Nicardipine (preferred for most emergencies) 1, 3:

• Initial: 5 mg/hr IV infusion 3
• Titrate by 2.5 mg/hr every 15 minutes 3
• Maximum: 15 mg/hr 3
• Advantages: Predictable titration, maintains cerebral blood flow, does not increase intracranial pressure 1

Labetalol (preferred for encephalopathy, eclampsia, aortic dissection) 1:

• Initial bolus: 10-20 mg IV over 1-2 minutes 1
• Repeat or double dose every 10 minutes 1
• Maximum cumulative dose: 300 mg 1
• Alternative: Continuous infusion at 2-8 mg/min 1
• Contraindications: Reactive airway disease, COPD, heart block, bradycardia, decompensated heart failure 1

Clevidipine (alternative first-line) 1:

• Initial: 1-2 mg/hr IV 1
• Double every 90 seconds until BP approaches target 1
• Maximum: 32 mg/hr 1
• Contraindication: Soy/egg allergy 1

Condition-Specific Modifications

Acute coronary syndrome or pulmonary edema 1:

• Use nitroglycerin IV: 5-10 mcg/min, titrate by 5-10 mcg/min every 5-10 minutes 1
• Target SBP <140 mmHg immediately 1
• Can combine with labetalol for heart rate control 1

Acute aortic dissection 1:

• Use esmolol plus nitroprusside/nitroglycerin 1
• Beta blockade MUST precede vasodilator to prevent reflex tachycardia 1
• Target SBP ≤120 mmHg within 20 minutes 1

Hypertensive encephalopathy 1:

• Nicardipine is superior—preserves cerebral blood flow 1
• Immediate MAP reduction by 20-25% 1

Eclampsia/preeclampsia 1:

• Use hydralazine, labetalol, or nicardipine 1
• Absolutely contraindicated: ACE inhibitors, ARBs, nitroprusside 1

Acute ischemic stroke 1:

• Avoid BP reduction unless BP >220/120 mmHg 1
• If eligible for reperfusion: Maintain BP <180/105 mmHg for first 24 hours 1
• If not receiving reperfusion and BP ≥220/110 mmHg: Reduce by approximately 15% over first 24 hours 1

Acute hemorrhagic stroke 1:

• If SBP ≥220 mmHg: Carefully lower to 140-160 mmHg within 6 hours 1
• If SBP <220 mmHg: Do not lower immediately 1

Medications to AVOID

• Immediate-release nifedipine: Unpredictable precipitous drops, reflex tachycardia 1, 4
• Sodium nitroprusside: Use only as last resort—risk of cyanide toxicity with prolonged use (>48-72 hours) or renal insufficiency 1, 4
• Hydralazine: Unpredictable response, prolonged duration 1

Essential Laboratory Evaluation

Order immediately 1:

• Complete blood count (hemoglobin, platelets)—assess for microangiopathic hemolytic anemia 1
• Basic metabolic panel (creatinine, sodium, potassium)—evaluate renal function 1
• Lactate dehydrogenase and haptoglobin—detect hemolysis in thrombotic microangiopathy 1
• Urinalysis for protein and urine sediment—identify renal damage 1
• Troponins if chest pain present—evaluate for acute coronary syndrome 1
• ECG—assess for cardiac involvement 1

---

Management of Hypertensive Urgency

Outpatient Management Approach

• Do NOT admit to hospital 2
• Do NOT use IV medications 2
• Initiate or adjust oral antihypertensive therapy 2
• Arrange outpatient follow-up within 2-4 weeks 2

Oral Medication Selection

For non-Black patients 1:

• Start low-dose ACE inhibitor (e.g., captopril 25 mg) or ARB 2
• Add dihydropyridine calcium channel blocker if needed 2
• Add thiazide/thiazide-like diuretic as third-line 1

For Black patients 2:

• Start ARB plus dihydropyridine calcium channel blocker OR 2
• Calcium channel blocker plus thiazide diuretic 2
• Add missing component as third-line 1

Blood Pressure Goals

• Reduce BP gradually over 24-48 hours, NOT acutely 1
• Target <130/80 mmHg (or <140/90 mmHg in elderly/frail) within 3 months 2
• Critical pitfall: Rapid BP lowering may cause cerebral, renal, or coronary ischemia in patients with chronic hypertension 2

Important Clinical Considerations

• Up to one-third of patients with diastolic BP >95 mmHg normalize spontaneously before follow-up 1
• Patients can be discharged even if BP remains >180/110 mmHg IF no acute target organ damage is present 1
• Many patients with acute pain or distress have transiently elevated BP that normalizes when underlying condition is treated 1

---

Post-Stabilization Management

Screen for Secondary Hypertension

• 20-40% of patients with malignant hypertension have identifiable secondary causes 1
• Evaluate for: renal artery stenosis, pheochromocytoma, primary aldosteronism, renal parenchymal disease 1

Address Medication Non-Adherence

• Medication non-compliance is the most common trigger for hypertensive emergencies 1

Transition to Oral Therapy

• After stabilization, transition to oral antihypertensive combination therapy 1
• Use RAS blockers, calcium channel blockers, and diuretics 1
• Target BP <130/80 mmHg for most patients 1

Follow-Up Requirements

• Frequent follow-up (at least monthly) until target BP reached and organ damage regressed 1
• Patients remain at significantly increased cardiovascular and renal risk compared to hypertensive patients without emergencies 1

---

Critical Pitfalls to Avoid

• Do not treat the BP number alone—assess for true hypertensive emergency before initiating aggressive therapy 1
• Do not lower BP to "normal" acutely in hypertensive emergency—altered autoregulation in chronic hypertension makes acute normalization dangerous 1
• Do not use IV medications for hypertensive urgency—oral therapy is appropriate 2
• Do not admit patients with asymptomatic hypertension without evidence of acute target organ damage 1
• Do not delay laboratory testing in hypertensive emergency—immediate assessment is crucial 1
• Do not overlook secondary hypertension—requires specific diagnostic workup after stabilization 1